Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Hisse Senetlerindeki Sıralama #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Hisse Fiyatı
$0.00023723
Son senkronizasyon: 2024-08-26
Piyasa Değeri
$1.41K
Değişim (1 gün)
111.67%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret Pharnext S.A. (ALPHA)

Kategori

Pharnext S.A. (ALPHA) için temettü verimi geçmişi
Pharnext S.A. (hisse sembolü: ALPHA) temettü verimi (TTM) 2022-12-31 itibariyle: 0.00%
Son 5 yılın ortalama temettü verimi: 0.00%
Pharnext S.A. (ALPHA) için 2012 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
Benzer şirketler veya rakiplerin temettü verimi (TTM)